Table 1.
Evidence salient to the hypothesis that endometriosis involves relative extremes of phenotypes that show evidence of sex differences in humans, due to genetic and environmental effects during development
Trait | Female–male sex difference, or variation among females | Pattern in endometriosis or its symptoms | References |
---|---|---|---|
Anogenital distance | Shorter in females than in males | Shorter in women with endometriosis compared to control women | [40, 41] |
2D4D digit ratio | Longer in females than in males | Longer in women with heavy menstrual bleeding and dysmenorrhea (menstrual pain during periods caused by contractions) | [46] |
Waist-to-hip ratio | Lower in women than in men | Lower in women with endometriosis than in control women | [47] |
Inflammation levels | Higher in women than in men, during reproductive period of female life history | Higher in women with endometriosis compared to control women and men | [21, 48] |
Pain (chronic) | Higher sensitivity in women than in men, and lower β-endorphin levels in women | Higher sensitivity to pain, and lower β-endorphin levels, in women with endometriosis compared to controls | See text for details |
Serum testosterone | Lower in women than men | Lower in women with endometriosis than in controls | [49] |
Serum oxytocin | Higher in women than in men | Higher in women with endometriosis than in control women | [50, 51] |
Timing of menarche and menopause | Varies among females | Earlier menarche and menopause in women with endometriosis | [52, 53] |
Length of menstrual cycle | Varies among females | Shorter menstrual cycle length in women with endometriosis | [54] |
Dysmenorrhea | Varies among females | Higher levels in women with endometriosis | [55] |
Bleeding during menstruation | Varies among females | Higher levels in women with endometriosis | [55] |